Parallel Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.22K | Buy |
56
+29
| +107% | +$629 | ﹤0.01% | 3135 |
|
|
2025
Q1 | $655 | Hold |
27
| – | – | ﹤0.01% | 3184 |
|
|
2024
Q4 | $563 | Buy |
27
+14
| +108% | +$292 | ﹤0.01% | 3179 |
|
|
2024
Q3 | $258 | Hold |
13
| – | – | ﹤0.01% | 3245 |
|
|
2024
Q2 | $201 | Hold |
13
| – | – | ﹤0.01% | 3189 |
|
|
2024
Q1 | $207 | Hold |
13
| – | – | ﹤0.01% | 3145 |
|
|
2023
Q4 | $219 | Hold |
13
| – | – | ﹤0.01% | 3160 |
|
|
2023
Q3 | $152 | Sell |
13
-140
| -92% | -$1.64K | ﹤0.01% | 3254 |
|
|
2023
Q2 | $2.06K | Hold |
153
| – | – | ﹤0.01% | 2744 |
|
|
2023
Q1 | $2.54K | Hold |
153
| – | – | ﹤0.01% | 2681 |
|
|
2022
Q4 | $2.85K | Hold |
153
| – | – | ﹤0.01% | 2546 |
|
|
2022
Q3 | $2K | Buy |
+153
| New | +$2K | ﹤0.01% | 2595 |
|
|
2021
Q1 | – | Sell |
-2
| Closed | – | – | 2792 |
|
|
2020
Q4 | $0 | Buy |
+2
| New | – | ﹤0.01% | 2566 |
|